Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06170944 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke

Study acronym: RICAS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Nov 30, 2025 to Nov 30, 2026
    • Study completion date: Jan 30, 2026 to Nov 30, 2027
    v5
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 1, 2024 to Jun 1, 2024
    v3
  4. Start date: Feb 1, 2024 to Apr 1, 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to explore the influence of chronic RIC on collateral status evaluated by DSA in ischemic stroke patients with LAA etiology.
Trial Details
NCT Number NCT06170944
Lead Sponsor General Hospital of Shenyang Military Region
Conditions
(from sponsor)		 Stroke, Ischemic
Related terms Ischemic Stroke
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov